First major milestone in AbVance project met, reports alliance

04:00 EST 10 Nov 2017 | EPM Magazine

A not-for-profit alliance focusing on innovation in life sciences R&D, the Pistoia Alliance, has reached the first key milestone in its AbVance project with the first release of antibody structures into a protein data bank

Original Article: First major milestone in AbVance project met, reports alliance


More From BioPortfolio on "First major milestone in AbVance project met, reports alliance"

Quick Search


Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...